Vantedge Buys Leading Medical Device Firm Hobson & Motzer

Vantedge Medical, backed by Aterian Investment Partners, has acquired US-based precision medical device manufacturer Hobson & Motzer. Although the financial details remain confidential, this acquisition aims to bolster Vantedge’s presence in the surgical stapler market and broaden its range of consumable products.

Additionally, the deal will enhance Vantedge's role as a key manufacturing partner for top-tier medical OEMs across the country. Established in 1912, Hobson & Motzer brings a wealth of experience and capabilities, including precision electrochemical machining, progressive stamping, and advanced tool and die operations.

Since being acquired by Aterian in May 2018, Vantedge has grown rapidly, adding five medical technology companies to its portfolio, building new production facilities, and investing in both equipment and workforce development. Today, Vantedge operates nine facilities across the US and employs over 1,200 people. The recent acquisition of Hobson & Motzer, facilitated by legal counsel from Weil Gotshal & Manges, marks another milestone in this growth.

Vantedge Medical chief commercial officer Greg Santorno stated, “Our union with Hobson & Motzer provides an expanded capability set that significantly increases the value we will deliver to our customers. The addition of precision progressive die stamping, unique value-add machining and assembly technologies, and a deep expertise in the manufacturing of surgical stapler anvils, complements our existing strengths serving the robotic-assisted surgery, surgical instrumentation, orthopaedics, ophthalmology, dental, drug delivery and medical diagnostics markets.”